QurCan Therapeutics (formerly Nanology Labs Inc) is a biotechnology company using advanced nanoparticle drug-delivery technology to unleash the immense potential of next-generation biological and genetic medicine and deliver life-changing therapeutics. QurCan's next generation nanoparticle platform, TERP, enables tissue-selective delivery of nucleotides and biological therapeutics to extra-hepatic sites, including brain and spleen. TERP technology is a breakthrough technology with the great potential to deliver a new era of disease-modifying genetic medicine that will make a difference to patients with a wide range of unmet medical needs.
| Website | http://www.qurcan.com |
| Employees | 10 (5 on RocketReach) |
| Founded | 2018 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Nanoparticle Drug Delivery, Biological Medicine, Genetic Medicine, Drug Delivery Systems, Advanced Drug Delivery, Nanoparticle Technology, Therapeutic Delivery, Biotechnology, Next Generation Medicine, Pharmaceutical Research, Drug Development, Clinical Trials, Biopharma, Innovative Therapies, Targeted Drug Delivery, Novel Therapeutics, Nanomedicine, Pharmaceutical Innovation |
| Competitors | Pfizer, Bayer, Amgen, Bristol Myers Squibb, AstraZeneca, Novartis, Gilead Sciences, Genentech, Merck AH, Lilly India +44 more (view full list) |
Looking for a particular QurCan Therapeutics Inc. employee's phone or email?
QurCan Therapeutics Inc. Questions
Mohammad Amini is the President and CEO of QurCan Therapeutics Inc..
5 people are employed at QurCan Therapeutics Inc..
Top QurCan Therapeutics Inc. Employees
-
John Reid
Chief Business Officer at QurCan Therapeutics Inc.
Toronto, ON, CA55+ -
Subha Dahal
Scientist at QurCan Therapeutics Inc.
Toronto, ON, CA1 -
Petro Czupiel
Associate Scientist at QurCan Therapeutics Inc.
Toronto, ON, CA
Related Companies
